These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 32252012)

  • 1. Development and implementation of large-scale quality control for the European bank for induced Pluripotent Stem Cells.
    O'Shea O; Steeg R; Chapman C; Mackintosh P; Stacey GN
    Stem Cell Res; 2020 May; 45():101773. PubMed ID: 32252012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The EBiSC iPSC bank for disease studies.
    Steeg R; Neubauer JC; Müller SC; Ebneth A; Zimmermann H
    Stem Cell Res; 2020 Dec; 49():102034. PubMed ID: 33099110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid establishment of the European Bank for induced Pluripotent Stem Cells (EBiSC) - the Hot Start experience.
    De Sousa PA; Steeg R; Wachter E; Bruce K; King J; Hoeve M; Khadun S; McConnachie G; Holder J; Kurtz A; Seltmann S; Dewender J; Reimann S; Stacey G; O'Shea O; Chapman C; Healy L; Zimmermann H; Bolton B; Rawat T; Atkin I; Veiga A; Kuebler B; Serano BM; Saric T; Hescheler J; Brüstle O; Peitz M; Thiele C; Geijsen N; Holst B; Clausen C; Lako M; Armstrong L; Gupta SK; Kvist AJ; Hicks R; Jonebring A; Brolén G; Ebneth A; Cabrera-Socorro A; Foerch P; Geraerts M; Stummann TC; Harmon S; George C; Streeter I; Clarke L; Parkinson H; Harrison PW; Faulconbridge A; Cherubin L; Burdett T; Trigueros C; Patel MJ; Lucas C; Hardy B; Predan R; Dokler J; Brajnik M; Keminer O; Pless O; Gribbon P; Claussen C; Ringwald A; Kreisel B; Courtney A; Allsopp TE
    Stem Cell Res; 2017 Apr; 20():105-114. PubMed ID: 28334554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EBiSC best practice: How to ensure optimal generation, qualification, and distribution of iPSC lines.
    Steeg R; Mueller SC; Mah N; Holst B; Cabrera-Socorro A; Stacey GN; De Sousa PA; Courtney A; Zimmermann H
    Stem Cell Reports; 2021 Aug; 16(8):1853-1867. PubMed ID: 34380020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Management of Data for the Banking, Qualification, and Distribution of Induced Pluripotent Stem Cells: Lessons Learned from the European Bank for Induced Pluripotent Stem Cells.
    Mah N; Kurtz A; Fuhr A; Seltmann S; Chen Y; Bultjer N; Dewender J; Lual A; Steeg R; Mueller SC
    Cells; 2023 Dec; 12(23):. PubMed ID: 38067184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scalable expansion of iPSC and their derivatives across multiple lineages.
    Kwok CK; Sébastien I; Hariharan K; Meiser I; Wihan J; Altmaier S; Karnatz I; Bauer D; Fischer B; Feile A; Cabrera-Socorro A; Rasmussen M; Holst B; Neubauer JC; Clausen C; Verfaillie C; Ebneth A; Hansson M; Steeg R; Zimmermann H
    Reprod Toxicol; 2022 Sep; 112():23-35. PubMed ID: 35595152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Copy number variant hotspots in Han Taiwanese population induced pluripotent stem cell lines - lessons from establishing the Taiwan human disease iPSC Consortium Bank.
    Huang CY; Li LH; Hsu WT; Cheng YC; Nicholson MW; Liu CL; Ting CY; Ko HW; Syu SH; Wen CH; Yan Z; Huang HP; Su HL; Chiang PM; Shen CN; Chen HF; Yen BLJ; Lu HE; Hwang SM; Chiou SH; Ho HN; Wu JY; Kamp TJ; Wu JC; Hsieh PCH
    J Biomed Sci; 2020 Sep; 27(1):92. PubMed ID: 32887585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of human leukocyte antigen matching in the development of multiethnic "haplobank" of induced pluripotent stem cell lines.
    Gourraud PA; Gilson L; Girard M; Peschanski M
    Stem Cells; 2012 Feb; 30(2):180-6. PubMed ID: 22045598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality Assurance in Stem Cell Banking: Emphasis on Embryonic and Induced Pluripotent Stem Cell Banking.
    Kallur T; Blomberg P; Stenfelt S; Tryggvason K; Hovatta O
    Methods Mol Biol; 2017; 1590():11-16. PubMed ID: 28353259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Stability and Differentiation Potential of Cryopreserved cGMP-Compliant Human Induced Pluripotent Stem Cells.
    Shafa M; Walsh T; Panchalingam KM; Richardson T; Menendez L; Tian X; Suresh Babu S; Dadgar S; Beller J; Yang F; Baghbaderani BA
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31877913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical Care Network in the State of Qatar.
    Hijjeh M; Al Shaikh L; Alinier G; Selwood D; Malmstrom F; Hassan IF
    Qatar Med J; 2019; 2019(2):2. PubMed ID: 31763205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Academic application of Good Cell Culture Practice for induced pluripotent stem cells.
    Tigges J; Bielec K; Brockerhoff G; Hildebrandt B; Hübenthal U; Kapr J; Koch K; Teichweyde N; Wieczorek D; Rossi A; Fritsche E
    ALTEX; 2021; 38(4):595-614. PubMed ID: 33963415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality control guidelines for clinical-grade human induced pluripotent stem cell lines.
    Sullivan S; Stacey GN; Akazawa C; Aoyama N; Baptista R; Bedford P; Bennaceur Griscelli A; Chandra A; Elwood N; Girard M; Kawamata S; Hanatani T; Latsis T; Lin S; Ludwig TE; Malygina T; Mack A; Mountford JC; Noggle S; Pereira LV; Price J; Sheldon M; Srivastava A; Stachelscheid H; Velayudhan SR; Ward NJ; Turner ML; Barry J; Song J
    Regen Med; 2018 Oct; 13(7):859-866. PubMed ID: 30205750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human-Induced Pluripotent Stem Cell Culture Methods Under cGMP Conditions.
    Rivera T; Zhao Y; Ni Y; Wang J
    Curr Protoc Stem Cell Biol; 2020 Sep; 54(1):e117. PubMed ID: 32649060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repurposing the Cord Blood Bank for Haplobanking of HLA-Homozygous iPSCs and Their Usefulness to Multiple Populations.
    Lee S; Huh JY; Turner DM; Lee S; Robinson J; Stein JE; Shim SH; Hong CP; Kang MS; Nakagawa M; Kaneko S; Nakanishi M; Rao MS; Kurtz A; Stacey GN; Marsh SGE; Turner ML; Song J
    Stem Cells; 2018 Oct; 36(10):1552-1566. PubMed ID: 30004605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-Free Transplantation of Patient-Derived Induced Pluripotent Stem Cell Progeny for Customized Islet Regeneration.
    El Khatib MM; Ohmine S; Jacobus EJ; Tonne JM; Morsy SG; Holditch SJ; Schreiber CA; Uetsuka K; Fusaki N; Wigle DA; Terzic A; Kudva YC; Ikeda Y
    Stem Cells Transl Med; 2016 May; 5(5):694-702. PubMed ID: 26987352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generating patient-specific induced pluripotent stem cells-derived cardiomyocytes for the treatment of cardiac diseases.
    Jeziorowska D; Korniat A; Salem JE; Fish K; Hulot JS
    Expert Opin Biol Ther; 2015; 15(10):1399-409. PubMed ID: 26134098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do Induced Pluripotent Stem Cell Characteristics Correlate with Efficient In Vitro Smooth Muscle Cell Differentiation? A Comparison of Three Patient-Derived Induced Pluripotent Stem Cell Lines.
    Zhou Y; Kang G; Wen Y; Briggs M; Sebastiano V; Pederson R; Chen B
    Stem Cells Dev; 2018 Oct; 27(20):1438-1448. PubMed ID: 30153084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Illustrating the potency of current Good Manufacturing Practice-compliant induced pluripotent stem cell lines as a source of multiple cell lineages using standardized protocols.
    Rao MS; Pei Y; Garcia TY; Chew S; Kasai T; Hisai T; Taniguchi H; Takebe T; Lamba DA; Zeng X
    Cytotherapy; 2018 Jun; 20(6):861-872. PubMed ID: 29793831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ensuring the Quality of Stem Cell-Derived In Vitro Models for Toxicity Testing.
    Stacey GN; Coecke S; Price AB; Healy L; Jennings P; Wilmes A; Pinset C; Ingelman-Sundberg M; Louisse J; Haupt S; Kidd D; Robitski A; Jahnke HG; Lemaitre G; Myatt G
    Adv Exp Med Biol; 2016; 856():259-297. PubMed ID: 27671727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.